A Study of 177Lu-FAP-2286 in Advanced Solid Tumors (LuMIERE)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Thomas Hope, MD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Thomas Hope, MD
Thomas Hope, MD, is the Director of Molecular Therapy in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. He is also the Associate Chair for Business Strategy for Radiology. He serves as Chief of Nuclear Medicine at the San Francisco VA Medical Center.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Clovis Oncology, Inc.
- ID
- NCT04939610
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Last Updated